A bone-like composite developed at EPFL uses naturally occurring enzymes to accelerate mineralization through an energy-efficient, room-temperature process. The strong, lightweight material shows promise for bone repair applications.
Mar 11, 2026
0
13
Living in zero gravity can lead to periodontitis, a common and serious condition where the gums become inflamed and the bone that supports teeth starts to break down, eventually leading to tooth loss, scientists reveal in ...
Jun 16, 2025
0
29
A clinical trial led by Birmingham researchers investigated targeting a molecule causing liver inflammation and fibrosis to treat patients with Primary sclerosing cholangitis (PSC)—a debilitating liver disease for which there ...
May 14, 2024
0
35
A team of UC Davis Health clinicians and data scientists has developed a machine-learning model to better predict which patients are at greater risk of developing a common type of liver cancer, hepatocellular carcinoma (HCC).
Feb 29, 2024
0
37
For patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline phosphatase normalization, according to ...
Feb 27, 2024
0
27
An international clinical trial involving UC Davis Health suggests the investigational drug Elafibranor is a potential novel treatment for patients with the rare, autoimmune disease primary biliary cholangitis. Results from ...
Nov 16, 2023
0
56
Yu Lei, professor of chemical and biomolecular engineering, has invented a new platform that can perform high-sensitivity readings for a variety of disease biomarkers.
Jul 27, 2022
0
58
